Diabetic myopathy: Impact of diabetes mellitus on skeletal muscle progenitor cells

Frontiers in Physiology

Volumn 4 DEC, Issue , 2013, Pages

  D'Souza, Donna M ^a   Al Sajee, Dhuha ^a   Hawke, Thomas J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Diabetes mellitus; Muscle regeneration; Muscle satellite cells; PICs; Skeletal muscle; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

CARBOHYDRATE; INTERLEUKIN 6; MYOGENIC FACTOR; NITRIC OXIDE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

CARBOHYDRATE METABOLISM; CELL POPULATION; DIABETES MELLITUS; DIABETIC MYOPATHY; HISTOPATHOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MUSCLE GROWTH; MUSCLE REGENERATION; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN METABOLISM; SHORT SURVEY; SKELETAL MUSCLE SATELLITE CELL; STEM CELL;

EID: 84891694035     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00379     Document Type: Short Survey

References (100)

1. Aguiari, P., Leo, S., Zavan, B., Vindigni, V., Rimessi, A., Bianchi, K., et al. (2008). High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc. Natl. Acad. Sci. U.S.A. 105, 1226-1231. doi: 10.1073/pnas.0711402105.
2. Almeida, S., Riddell, M. C., and Cafarelli, E. (2008). Slower conduction velocity and motor unit discharge frequency are associated with muscle fatigue during isometric exercise in Type 1 diabetes mellitus. Muscle Nerve 37, 231-240. doi: 10.1002/mus.20919.
3. Alter, J., Rozentzweig, D., and Bengal, E. (2008). Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor. J. Biol. Chem. 283, 23224-23234. doi: 10.1074/jbc.M801379200.
4. American Diabetes Association. (2006). Diagnosis and classification of diabetes mellitus. Diabetes Care 29, 43-48. doi: 10.2337/dc09-S062.
5. Andersen, H., Gadeberg, P. C., Brock, B., and Jakobsen, J. (1997). Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 40, 1062-1069. doi: 10.1007/s001250050788.
6. Andersen, H., Gjerstad, M. D., and Jakobsen, J. (2004). Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 27, 2382-2385. doi: 10.2337/diacare.27.10.2382.
7. Andersen, H., Poulsen, P. L., Mogensen, C. E., and Jakobsen, J. (1996). Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes 45, 440-445. doi: 10.2337/diab.45.4.440.
8. Andersen, H., Schmitz, O., and Nielsen, S. (2005). Decreased isometric muscle strength after acute hyperglycaemia in Type 1 diabetic patients. Diabet. Med. 22, 1401-1407. doi: 10.1111/j.1464-5491.2005.01649.x.
9. Aragno, M., Mastrocola, R., Catalano, M. G., Brignardello, E., Danni, O., and Boccuzzi, G. (2004). Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 53, 1082-1088. doi: 10.2337/diabetes.53.4.1082.
10. Berria, R., Wang, L., Richardson, D. K., Finlayson, J., Belfort, R., Pratipanawatr, T., et al. (2006). Increased collagen content in insulin-resistant skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 290, E560-E565. doi: 10.1152/ajpendo.00202.2005.
11. Bonnefont-Rousselot, D. (2002). Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 5, 561-568. doi: 10.1097/00075197-200209000-00016.
12. Brannon, M. A., Dodson, M. V., Wheeler, B. A., Mathison, B. D., and Mathison, B. A. (1989). Satellite cells derived from streptozotocin-diabetic rats display altered fusion parameters in vitro. Metab. Clin. Exp. 38, 348-352. doi: 10.1016/0026-0495(89)90123-6.
13. Broholm, C., Brandt, C., Schultz, N. S., Nielsen, A. R., Pedersen, B. K., and Scheele, C. (2012). Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with Type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 303, E283-E292. doi: 10.1152/ajpendo.00586.2011.
14. Cassar-Malek, I., Langlois, N., Picard, B., and Geay, Y. (1999). Regulation of bovine satellite cell proliferation and differentiation by insulin and triiodothyronine. Domest. Anim. Endocrinol. 17, 373-388. doi: 10.1016/S0739-7240(99)00055-7.
15. Charlton, M., and Nair, K. S. (1998). Protein metabolism in insulin-dependent diabetes mellitus. J. Nutr. 128, 323S-327S.
16. Chomentowski, P., Coen, P. M., Radiková, Z., Goodpaster, B. H., and Toledo, F. G. (2011). Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J. Clin. Endocrinol. Metab. 96, 494-503. doi: 10.1210/jc.2010-0822.
17. Crowther, G. J., Milstein, J. M., Jubrias, S. A., Kushmerick, M. J., Gronka, R. K., and Conley, K. E. (2003). Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (type 1) diabetes. Am. J. Physiol. Endocrinol. Metab. 284, E655-E662. doi: 10.1152/ajpendo.00343.2002.
18. Csizuadia, E., Qipo, A., Libermann, T. A., Strom, T. B., Bhasin, M., Awdeh, Z., et al. (2012). The role of TNF-α in mice with Type 1-and 2-diabetes. PLoS ONE 7:e33254. doi: 10.1371/journal.pone.0033254.
19. Darr, K. C., and Schultz, E. (1989). Hindlimb suspension suppresses muscle growth and satellite cell proliferation. J. Appl. Physiol. 67, 1827-1834.
20. DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., and Felber, J. P. (1981). The effect of insulin on the disposal of intravenous glucose. results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000-1007. doi: 10.2337/diab.30.12.1000.
21. Evans, J. L., Goldfine, I. D., Maddux, B. A., and Grodsky, G. M. (2002). Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of Type 2 diabetes. Endocr. Rev. 23, 599-622. doi: 10.1210/er.2001-0039.
22. Ewton, Z., and Florini, R. (1981). Effects of the somatomedins differentiation and insulin on myoblast in vitro. Dev. Biol. 39, 31-39. doi: 10.1016/0012-1606(81)90312-2.
23. Fitzpatrick, C., Wagers, A. J., Woo, M., Jimenez-Chillaron, J., Patti, M. E., Cerletti, M., et al. (2011). Early life nutrition modulates muscle stem cell number: implications for muscle mass and repair. Stem Cells Dev. 20, 1763-1769. doi: 10.1089/scd.2010.0349.
24. Franceschi, C. (2007). Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr. Rev. 65, S173-S176. doi: 10.1301/nr.2007.dec.S173-S176.
25. Fritzsche, K., Blüher, M., Schering, S., Buchwalow, I. B., Kern, M., Linke, A., et al. (2008). Metabolic profile and nitric oxide synthase expression of skeletal muscle fibers are altered in patients with Type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 116, 606-613. doi: 10.1055/s-2008-1073126.
26. Fulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., et al. (2008). Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 14, 661-673. doi: 10.1016/j.devcel.2008.02.004.
27. Gale, E. A. M. (2002). A missing link in the hygiene hypothesis? Diabetologia 45, 588-594. doi: 10.1007/s00125-002-0801-1.
28. Gaster, M., Petersen, I., Højlund, K., Poulsen, P., and Beck-Nielsen, H. (2002). The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51, 921-927. doi: 10.2337/diabetes.51.4.921.
29. Gaster, M., Rustan, A. C., Aas, V., and Beck-Nielsen, H. (2004). Reduced lipid oxidation in skeletal muscle from Type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53, 542-548. doi: 10.2337/diabetes.53.3.542.
30. Gopinath, S. D., and Rando, T. A. (2008). Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell 7, 590-598. doi: 10.1111/j.1474-9726.2008.00399.x.
31. Gordon, C. S., Serino, A. S., Krause, M. P., Campbell, J. E., Cafarelli, E., Adegoke, O. A., et al. (2010). Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent Type 1 diabetic myopathy? PLoS ONE 5:e14032. doi: 10.1371/journal.pone.0014032.
32. Green, C. J., Scheele, C., Pedersen, B. K., and Pedersen, M. (2011). Elevated NF-B activation is conserved in human myocytes cultured from obese Type 2 diabetic patients and attenuated by AMP-activated protein kinase. Diabetes 60, 2810-2819. doi: 10.2337/db11-0263.
33. Gulati, A. K., and Swamy, M. S. (1991). Regeneration of skeletal muscle in streptozotocin-induced diabetic rats. Anat. Rec. 229, 298-304. doi: 10.1002/ar.1092290303.
34. Hawke, T. J., and Garry, D. J. (2001). Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551. doi: 10.1063/1.3603452.
35. Henriksen, E. J., Diamond-Stanic, M. K., and Marchionne, E. M. (2010). Oxidative stress and the etiology of insulin resistance and Type 2 diabetes. Free Radic. Biol. Med. 51, 993-999. doi: 10.1016/j.freeradbiomed.2010.12.005.
36. Hilton, T. N., Tuttle, L. J., Bohnert, K. L., Mueller, M. J., and Sinacore, D. R. (2008). Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys. Ther. 88, 1336-1344. doi: 10.2522/ptj.20080079.
37. Hopps, E., and Caimi, G. (2012). Matrix metalloproteinases in metabolic syndrome. Eur. J. Intern. Med. 23, 99-104. doi: 10.1016/j.ejim.2011.09.012.
38. Hu, Z., Wang, H., Lee, I. H., Modi, S., Wang, X., Du, J., et al. (2010). PTEN inhibition improves muscle regeneration in mice fed a high-fat diet. Diabetes 59, 1312-1320. doi: 10.2337/db09-1155.
39. Huang, B. K., Monu, J. U., and Doumanian, J. (2010). Diabetic myopathy: MRI patterns and current trends. Am. J. Roentgenol. 195, 198-204. doi: 10.2214/AJR.09.2494.
40. Huttunen, N. P., Kaar, M. L., Knip, M., Mustonen, A., Puukka, R., and Akerblom, H. K. (1984). Physical fitness of children and adolescents with insulin-dependent diabetes mellitus. Ann. Clin. Res. 16, 1-5.
41. Jeong, J., Conboy, M. J., and Conboy, I. M. (2013). Pharmacological inhibition of myostatin/TGF-β receptor/pSmad 3 signaling rescues muscle regenerative responses in mouse model of type 1 diabetes. Acta. Pharmacol. Sin. 34, 1052-1060. doi: 10.1038/aps.2013.67.
42. Kelley, D. E., and Mandarino, L. J. (2000). Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49, 677-683. doi: 10.2337/diabetes.49.5.677.
43. Kivelä, R., Silvennoinen, M., Touvra, A. M., Lehti, T. M., Kainulainen, H., and Vihko, V. (2006). Effects of experimental Type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J. 20, 1570-1572. doi: 10.1096/fj.05-4780fje.
44. Koh, T. J., Bryer, S. C., Pucci, A. M., and Sisson, T. H. (2005). Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am. J. Physiol. Cell Physiol. 289, C217-C223. doi: 10.1152/ajpcell.00555.2004.
45. Krause, M. P., Al-Sajee, D., D'Souza, D. M., Rebalka, I. A., Moradi, J., Riddell, M. C., et al. (2013). Impaired macrophage and satellite cell infiltration occurs in a muscle-specific fashion following injury in diabetic skeletal muscle. PLoS ONE 8:e70971. doi: 10.1371/journal.pone.0070971.
46. Krause, M. P., Moradi, J., Nissar, A. A., Riddell, M. C., and Hawke, T. J. (2011). Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated Type 1 diabetic mice. Diabetes 60, 1964-1972. doi: 10.2337/db11-0007.
47. Krause, M. P., Riddell, M. C., Gordon, C. S., Imam, S. A., Cafarelli, E., and Hawke, T. J. (2009). Diabetic myopathy differs between Ins2Akita+/-and streptozotocin-induced Type 1 diabetic models. J. Appl. Physiol. 106, 1650-1659. doi: 10.1152/japplphysiol.91565.2008.
48. Kurtz, A., and Oh, S. J. (2012). Age related changes of the extracellular matrix and stem cell maintenance. Prev. Med. Suppl:S50-S56. doi: 10.1016/j.ypmed.2012.01.003.
49. Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., et al. (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18, 39-51. doi: 10.1096/fj.03-0610com.
50. Lecker, S. H., Solomon, V., Price, S. R., Kwon, Y. T., Mitch, W. E., and Goldberg, A. L. (1999). Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J. Clin. Invest. 104, 1411-1420. doi: 10.1172/JCI7300.
51. Lee, S. W., Dai, G., Hu, Z., Wang, X., Du, J., and Mitch, W. E. (2004). Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J. Am. Soc. Nephrol. 15, 1537-1545. doi: 10.1097/01.ASN.0000127211.86206.E1.
52. Leinonen, H., Matikainen, E., and Juntunen, J. (1982). Permeability and morphology of skeletal muscle capillaries in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 22, 158-162. doi: 10.1007/BF00283744.
53. Li, Y. P., Lecker, S. H., Chen, Y., Waddell, I. D., Goldberg, A. L., and Reid, M. B. (2003). TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J. 17, 1048-1057. doi: 10.1096/fj.02-0759com.
54. Li, Y. P., Schwartz, R. J., Waddell, I. D., Holloway, B. R., and Reid, M. B. (1998). Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J. 12, 871-880.
55. Llauradó, G., Gallart, L., Tirado, R., Megia, A., Simón, I., Caixàs, A., et al. (2012). Insulin resistance, low-grade inflammation and Type 1 diabetes mellitus. Acta Diabetol. 49, 33-39. doi: 10.1007/s00592-011-0257-1.
56. Lluís, F., Roma, J., Suelves, M., Parra, M., Aniorte, G., Gallardo, E., et al. (2001). Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood 97, 1703-1711. doi: 10.1182/blood.V97.6.1703.
57. Mårin, P., Andersson, B., Krotkiewski, M., and Björntorp, P. (1994). Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17, 382-386. doi: 10.2337/diacare.17.5.382.
58. Masso-Gonzalez, E., Johansson, S., Wallander, M.-A., and Garcia-Rodriguez, L. (2009). Trends in the prevalence and incidence of diabetes in the UK-1996 to 2005. J. Epidemiol. Community Health 63, 332-336. doi: 10.1136/jech.2008.080382.
59. Mastrocola, R., Reffo, P., Penna, F., Tomasinelli, C. E., Boccuzzi, G., Baccino, F. M., et al. (2008). Muscle wasting in diabetic and in tumor-bearing rats: role of oxidative stress. Free Radic. Biol. Med. 44, 584-593. doi: 10.1016/j.freeradbiomed.2007.10.047.
60. McKay, B. R., Ogborn, D. I., Baker, J. M., Toth, K. G., Tarnopolsky, M. A., and Parise, G. (2013). Elevated SOCS3 and altered IL-6 signaling is associated with age-related human muscle stem cell dysfunction. Am. J. Physiol. Cell Physiol. 304, C717-C728. doi: 10.1152/ajpcell.00305.2012.
61. Mitch, W. E., Bailey, J. L., Wang, X., Jurkovitz, C., Newby, D., and Price, S. R. (1999). Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol. 276, C1132-C1138.
62. Mozdziak, P. E., Pulvermacher, P. M., and Schultz, E. (2000). Unloading of juvenile muscle results in a reduced muscle size 9 wk after reloading. J. Appl. Physiol. 88, 158-164.
63. Nguyen, M.-H., Cheng, M., and Koh, T. J. (2011). Impaired muscle regeneration in Ob/ob and Db/db mice. ScientificWorldJournal 11, 1525-1535. doi: 10.1100/tsw.2011.137.
64. Nielsen, A. R., Kelly, M., Fischer, C. P., Pedersen, M., Broholm, C., Taudorf, S., et al. (2012). Satellite cells derived from obese humans with Type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS ONE 7:0039657. doi: 10.1371/journal.pone.0039657.
65. Nielsen, J., Mogensen, M., Vind, B. F., Sahlin, K., Højlund, K., Schrøder, H. D., et al. (2010). Increased subsarcolemmal lipids in Type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 298, E706-E713. doi: 10.1152/ajpendo.00692.2009.
66. Nyholm, B., Qu, Z., Kaal, A., Pedersen, S. B., Gravholt, C. H., Andersen, J. L., et al. (1997). Evidence of an increased number of Type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 46, 1822-1828. doi: 10.2337/diab.46.11.1822.
67. Onkamo, P., Väänänen, S., Karvonen, M., and Tuomilehto, J. (1999). Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 42, 1395-1403. doi: 10.1007/s001250051309.
68. Osborn, O., and Olefsky, J. M. (2012). The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363-374. doi: 10.1038/nm.2627.
69. Pain, V. M., Albertse, E. C., and Garlick, P. J. (1983). Protein metabolism in skeletal muscle, diaphragm, and heart of diabetic rats. Am. J. Physiol. 245, E604-E610.
70. Pannérec, A., Marazzi, G., and Sassoon, D. (2012). Stem cells in the hood: the skeletal muscle niche. Trends Mol. Med. 18, 599-606. doi: 10.1016/j.molmed.2012.07.004.
71. Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., de Rekeneire, N., Harris, T. B., Schwartz, A. V., et al. (2006). Decreased muscle strength and quality in older adults with Type 2 diabetes: the health, aging, and body composition study. Diabetes 55, 1813-1818. doi: 10.2337/db05-1183.
72. Peterson, J. M., Bryner, R. W., and Alway, S. E. (2008). Satellite cell proliferation is reduced in muscles of Obese Zucker Rats but restored with loading. Am. J. Physiol. Cell Physiol. 295, C521-C528. doi: 10.1152/ajpcell.00073.2008.
73. Poortmans, J. R., Saerens, P., Edelman, R., Vertongen, F., and Dorchy, H. (1986). Influence of the degree of metabolic control on physical fitness in Type I diabetic adolescents. Int. J. Sports Med. 7, 232-235. doi: 10.1055/s-2008-1025765.
74. Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E., and Ridker, P. M. (2001). C-reactive protein, interleukin 6, and risk of developing Type 2 diabetes mellitus. J. Am. Med. Assoc. 286, 327-334. doi: 10.1001/jama.286.3.327.
75. Price, S. R., Bailey, J. L., Wang, X., Jurkovitz, C., England, B. K., Ding, X., et al. (1996). Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest. 98, 1703-1708. doi: 10.1172/JCI118968.
76. Prior, S. J., McKenzie, M. J., Joseph, L. J., Ivey, F. M., Macko, R. F., Hafer-Macko, C. E., et al. (2009). Reduced skeletal muscle capillarization and glucose intolerance. Microcirculation 16, 203-212. doi: 10.1080/10739680802502423.
77. Ramasamy, R., Vannucci, S. J., Yan, S. S., Herold, K., Yan, S. F., and Schmidt, A. M. (2005). Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15, 16R-28R. doi: 10.1093/glycob/cwi053.
78. Renault, V., Thornell, L. E., Eriksson, P. O., Butler-Browne, G., and Mouly, V. (2002). Regenerative potential of human skeletal muscle during aging. Aging Cell 1, 132-139. doi: 10.1046/j.1474-9728.2002.00017.x.
79. Reis, J. S., Amaral, C. A., Volpe, C. M., Fernandes, J. S., Borges, E. A., Isoni, C. A., et al. (2012). Oxidative stress and interleukin-6 secretion during the progression of type 1 diabetes. Arg. Bras. Endocrinol. Metabol. 56, 441-448. doi: 10.1590/S0004-27302012000700006.
80. Romanatto, T., Roman, E. A., Arruda, A. P., Denis, R. G., Solon, C., Milanski, M., et al. (2009). Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J. Biol. Chem. 284, 36213-36222. doi: 10.1074/jbc.M109.030874.
81. Romer, J., Bugge, T. H., Pyke, C., Lund, L. R., Flick, M. J., Degen, J. L., et al. (1996). Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med. 2, 287-292. doi: 10.1038/nm0396-287.
82. Roubenoff, R. (1997). Inflammatory and hormonal mediators of cachexia. J. Nutr. 127, 1014S-1016S.
83. Ryall, J. G. (2013). Metabolic reprogramming as a novel regulator of skeletal muscle development and regeneration. FEBS J. 280, 4004-4013. doi: 10.1111/febs.12189.
84. Scarda, A., Franzin, C., Milan, G., Sanna, M., Dal Prà, C., Pagano, C., et al. (2010). Increased adipogenic conversion of muscle satellite cells in Obese Zucker Rats. Int. J. Obes. 34, 1319-1327. doi: 10.1038/ijo.2010.47.
85. Shaw, J. E., Sicree, R. A., and Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4-14. doi: 10.1016/j.diabres.2009.10.007.
86. Shimizu, M., Hara, A., Okuno, M., Matsuno, H., Okada, K., Ueshima, S., et al. (2001). Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after fas-mediated massive hepatic apoptosis. Hepatology 33, 569-576. doi: 10.1053/jhep.2001.22650.
87. Swaroop, J. J., Rajarajeswari, D., and Naidu, J. N. (2012). Association of TNF-α with insulin resistance in Type 2 diabetes mellitus. Indian J. Med. Res. 135, 127-130. doi: 10.4103/0971-5916.93435.
88. Talesara, C. L., and Vashishta, N. (2000). Regenerative ability of gastrocnemius muscle under diabetic condition with special reference to SDH & m-ATPase. Indian J. Exp. Biol. 38, 567-574.
89. Tan, K. C., Chow, W. S., Tam, S., Bucala, R., and Betteridge, J. (2004). Association between acute-phase reactants and advanced glycation end products in Type 2 diabetes. Diabetes Care 27, 223-228. doi: 10.2337/diacare.27.1.223.
90. Toth, K. G., McKay, B. R., De Lisio, M., Little, J. P., Tarnopolsky, M. A., and Parise, G. (2011). IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS ONE 6:0017392. doi: 10.1371/journal.pone.0017392.
91. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., and Hotamisligil, G. S. (1997). Protection from obesity-induced insulin-resistance in mice lacking Tnf-alpha function. Nature 389, 610-614. doi: 10.1038/39335.
92. Vandenburgh, H. H., Karlisch, P., Shansky, J., and Feldstein, R. (1991). Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am. J. Physiol. 260, C475-C484.
93. Vasilaki, A., and Jackson, M. J. (2013). Role of reactive oxygen species in the defective regeneration seen in aging muscle. Free Radic. Biol. Med. 65, 317-323. doi: 10.1016/j.freeradbiomed.2013.07.008.
94. Vettor, R., Milan, G., Franzin, C., Sanna, M., De Coppi, P., Rizzuto, R., et al. (2009). The origin of intermuscular adipose tissue and its pathophysiological implications. Am. J. Physiol. Endocrinol. Metab. 297, E987-E998. doi: 10.1152/ajpendo.00229.2009.
95. Vignaud, A., Ramond, F., Hourdé, C., Keller, A., Butler-Browne, G., and Ferry, A. (2007). Diabetes provides an unfavorable environment for muscle mass and function after muscle injury in mice. Pathobiology 74, 291-300. doi: 10.1159/000105812.
96. Yan, S. F., Ramasamy, R., and Schmidt, A. M. (2008). Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat. Clin. Pract. Endocrinol. Metab. 4, 285-293. doi: 10.1038/ncpendmet0786.
97. Yoon, J. H., Song, P., Jang, J. H., Kim, D. K., Choi, S., Kim, J., et al. (2011). Proteomic analysis of tumor necrosis factor-alpha (TNF-alpha)-induced L6 myotube secretome reveals novel TNF-alpha-dependent myokines in diabetic skeletal muscle. J. Proteome Res. 10, 5315-5325. doi: 10.1021/pr200573b.
98. Zammit, P. S., and Relaix, F. (2012). Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139, 2845-2856. doi: 10.1242/dev.069088.
99. Zhou, L. Z., Johnson, A. P., and Rando, T. A. (2001). NF Kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 31, 1405-1416. doi: 10.1016/S0891-5849(01)00719-5.
100. Zou, M.-H., Shi, C., and Cohen, R. A. (2002). Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 31, 1405-1416. doi: 10.1172/JCI14442.